Arineta

Imaging Solutions for Cardiac Care

Health Tech & Life Sciences
Active
Mature Caesarea Founded 2006
Total raised
$10.0M
Last: Series A 2011-11
Stage
Mature
Founded
2006
Headcount
93
HQ
Caesarea
Sector
Health Tech & Life Sciences

About

Arineta develops and produces cardiovascular imaging solutions. Arineta's flagship product is CardioGraphe, a dedicated single-heartbeat, whole-heart cardiac CT scanner based on the company's proprietary Stereo CT technology. CardioGraphe is designed to provide comprehensive clinical information for diagnosis and therapy planning. It is optimized for imaging the entire heart and cardiovascular system with 140-mm coverage at a rotation speed of 0.24 seconds per rotation. The system uses a lower radiation dose than whole-body CT scanners. Further, the imaging based on a single heartbeat and the fast speed of the scan reduce contrast volumes and the need for a beta blocker. Clinical applications from calcium scoring to cardiac CTA and peripheral vascular imaging can be executed easily and successfully even for obese patients or those with high or unstable heart rates. CardioGraphe is distributed globally by GE Healthcare. The product has regulatory clearance in the United States, Canada, European Union, and other regions. It is installed and operates successfully in hospitals in North America, Europe, China, and Israel.

Funding history · 1 round · $10.0M total

2011-11
Series A $10.0M

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & TherapeuticsDiagnostics Devices
Technologies
Simulation & Imaging
Target customers
Healthcare & Life SciencesHealthcareProvidersCommerce & RetailDistribution ChannelsDistributor
Business model
B2B

Highlights

1 Patents

Tags

diagnosticsimagingcardiovascularpatent-pendinghospitalsmedical-devicesct-scancardiologytherapeuticsoptronicsmedical-technologies